Search
for
Sort by
Research 30 of 1000+
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Effect of Alexandrite Laser Hair Removal on the Activity of Systemic Lupus Erythematosus
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
- Hair diameter in systemic lupus erythematosus
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity
- AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Cross‐sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: A frequent finding of non‐scarring patch alopecia
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort
- Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Research on the correlation between rash and complement C3, C4 levels and the occurrence and development of lupus nephritis
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases
- S2:04 Decoding fatigue in systemic lupus erythematosus with artificial intelligence: hematologic or inflammatory factors?
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- Chinese SLE Treatment and Research group (CSTAR) registry 2009–2019: Major clinical characteristics of Chinese patients with systemic lupus erythematosus
- Involvement of scalp and nails in lupus erythematosus